A clinical assessment of loading dose tamoxifen for advanced breast carcinoma.
dc.contributor.author | Ribeiro, G | |
dc.contributor.author | Wilkinson, Peter M | |
dc.date.accessioned | 2011-03-03T14:46:33Z | |
dc.date.available | 2011-03-03T14:46:33Z | |
dc.date.issued | 1984-12 | |
dc.identifier.citation | A clinical assessment of loading dose tamoxifen for advanced breast carcinoma. 1984, 10 (4):363-7 Clin Oncol | en |
dc.identifier.issn | 0305-7399 | |
dc.identifier.pmid | 6509818 | |
dc.identifier.uri | http://hdl.handle.net/10541/123467 | |
dc.description.abstract | Seventy patients with advanced breast carcinoma were treated with a loading dose regimen of 160 mg Tamoxifen on day 1 followed by a maintenance dose of 20 mg daily from day 2 onwards. Compliance was 100% and only 3 patients developed mild side effects. In 27% regression of disease was observed within 1 month and in 57% within 2 months. This regimen is recommended for routine clinical use. | |
dc.language.iso | en | en |
dc.subject | Breast Cancer | en |
dc.subject | Oestrogen Receptors | en |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Breast Neoplasms | |
dc.subject.mesh | Drug Evaluation | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Receptors, Estrogen | |
dc.subject.mesh | Tamoxifen | |
dc.subject.mesh | Time Factors | |
dc.title | A clinical assessment of loading dose tamoxifen for advanced breast carcinoma. | en |
dc.type | Article | en |
dc.identifier.journal | Clinical Oncology | en |
html.description.abstract | Seventy patients with advanced breast carcinoma were treated with a loading dose regimen of 160 mg Tamoxifen on day 1 followed by a maintenance dose of 20 mg daily from day 2 onwards. Compliance was 100% and only 3 patients developed mild side effects. In 27% regression of disease was observed within 1 month and in 57% within 2 months. This regimen is recommended for routine clinical use. |